Skip to content
10-Q

Quarterly Report

AVAI BIO, INC. AVAI

0001740797-25-000014

← back to feed
Filed
Feb 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Feb 5, 2025 137.13M sh
Short Term Debt Q3 2025 · Dec 31, 2024 $30K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.07K
Cash And Equivalents Q3 2025 · Mar 31, 2024 $281
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.14M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$1.82M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$2.08M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$1.47M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.31M
Current Liabilities Q3 2025 · Mar 31, 2024 $1.79M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.31M
Total Liabilities Q3 2025 · Mar 31, 2024 $1.79M
Current Assets Q3 2025 · Dec 31, 2024 $27.51K
Current Assets Q3 2025 · Mar 31, 2024 $116.08K
Total Assets Q3 2025 · Dec 31, 2024 $174.89K
Total Assets Q3 2025 · Mar 31, 2024 $322.01K
Net Income Q3 2025 · Dec 31, 2024 −$1.61M
Net Income Q3 2025 · Dec 31, 2023 −$1.01M
Net Income Q3 2025 · Dec 31, 2023 −$1.83M
Net Income Q3 2025 · Sep 30, 2023 −$399.62K
Net Income Q3 2025 · Jun 30, 2023 −$411.52K
Operating Cash Flow Q3 2025 · Dec 31, 2023 −$1.19M
Eps Basic Q3 2025 · Dec 31, 2023 −$0.01
Eps Basic Q3 2025 · Dec 31, 2023 −$0.03
Sga Expense Q3 2025 · Dec 31, 2023 $985.59K
Sga Expense Q3 2025 · Dec 31, 2023 $1.72M